英文别名 |
prostaglandin a2;MEDULLIN;PGA2;Prostaglandin A;Prostaglandin A2 solution;PROSTAGLANDINS A2;pga(sup2);(155)-pga2;5,6-cis-pga(sup2);prostaglandina(sup2);PGA2 (Prostaglandin A2);(+)-prostaglandina(sup2);PGA2;Medullin;GTPL6279;K6VT5BDY9E;HY-113041;SCHEMBL2115595;(Z)-7-((1R,2S)-2-((E)-(3S)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic acid;Q27088462;(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic acid;NCGC00022061-04;15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate;15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic acid;IDI1_033930;5,6-cis-PGA(sup 2);C05953;Prostaglandin A(sup 2);362927F3-3A3E-47BC-84C3-C32A293AA956;DTXSID20864388;(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic acid;PROSTAGLANDIN A2 (PGA2);NCGC00022061-05;HMS1989I22;Pga2(prostaglandin a2);NCGC00022061-03;SMR000058790;LMFA03010035;BRD-K34782918-001-02-5;15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate;9-oxo-15S-hydroxy-5Z,10Z,13E-prostatrienoic acid;HMS3648I11;SR-01000946222-1;15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid;15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoate;(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic acid;HMS3402I22;Prosta-5,10,13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-;15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate;PGA(sup 2);(+)-Prostaglandin A(sup 2);15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic acid;15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic acid;SR-01000946222;prostaglandin A2;CHEBI:27820;NSC-165561;Prosta-5,10-13-trien-1-oic acid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-;DINOPROSTONE IMPURITY, (5Z,13E,15S)-15-HYDROXY-9-OXOPROSTA-5, 10,13-TRIENE-1-OIC ACID- [USP IMPURITY];HMS1791I22;5-Heptenoic acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (VAN);MLS000069589;CHEMBL1084643;5,6-cis-PGA2;(+)-Prostaglandin A2;15(S)-Prostaglandin A2;BRN 2221844;15.alpha.-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid;UNII-K6VT5BDY9E;BSPBio_001460;DINOPROSTONE IMPURITY D [EP IMPURITY];CS-0059420;15a-Hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic acid;AKOS040755328;BML1-F02;(Z)-7-[(1R,2S)-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic acid;(~{Z})-7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic acid;13345-50-1;HMS1361I22;Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-;(15S)-PGA2;(5Z,13E,15S)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid;NSC 165561;7-[2-(3-Hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl]-5-heptenoic acid;Prostaglandin A-2;10,13-trans-prostatrienoic Acid; 15(S)-Hydroxy-9-oxo-5-cis-10,13-trans-prostenoic Acid; 15(S)-Prostaglandin A2; 15a-Hydroxy-9-oxo-cis-5,10,trans-;7-(2-(3-Hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)-5-heptenoic acid;(Z)-7-((1R,2S)-2-((E)-3-hydroxyoct-1-enyl)-5-oxocyclo... |